GE Healthcare Technologies (GEHC) said Sunday it submitted 510(k) filings to the US Food and Drug Administration, seeking approval for its new Signa magnetic resonance imaging, or MRI, technology.
The technology includes the Signa Bolt MRI scanner and the Signa Sprint with Freelium sealed magnet MRI system.
GE Healthcare also said it is integrating Nvidia (NVDA) technology to improve its magnetic resonance products' performance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments